Viewing Study NCT03721757


Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2026-06-02 @ 9:31 PM
Study NCT ID: NCT03721757
Status: COMPLETED
Last Update Posted: 2025-02-25
First Post: 2018-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer
Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module